{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:27:50Z","timestamp":1789831670523,"version":"4.0.1"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"34","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["SBI-167982"],"award-info":[{"award-number":["SBI-167982"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Homozygous familial hypercholesterolaemia (HoFH) is an orphan disease defined by extreme elevations in low-density lipoprotein cholesterol, cutaneous xanthomas, and pre-mature atherosclerotic cardiovascular disease. Survival has more than doubled over the past three decades. Aortic stenosis (AS) [supravalvular aortic stenosis (SVAS) or valvular aortic stenosis (VAS)] is commonly encountered. There are no medical treatments available and complex high-risk surgeries represent the only available option in severe cases. A systematic review was performed to summarize the current evidence on AS in HoFH and to determine whether pharmacological treatment (statins) have had an impact on clinical presentation, phenotype and clinical course over the past nine decades (PROSPERO CRD42021250565).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>MEDLINE, Embase Classic\u2009+\u2009Embase, Cochrane Central Register of Controlled Trials, PubMed, AfricaWide, and Scopus were searched from inception to 10 November 2021. Searches identified 381 publications, of which 19 were retained; they were cross-sectional or retrospective studies. Separately, 108 individual case reports were described. Within the 424 HoFH cases, AS was identified in 57% of patients in the pre-statin era vs. 35% in patients reported more recently (&amp;gt;2000, long-term statin period). With an increase in longevity due to statins and lipoprotein apheresis, a change in the proportion of patients with SVAS and VAS with a SVAS:VAS ratio of 47:53 and 10:90 for HoFH patients not on statin and on long-term statin, respectively, was noted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These data suggest that SVAS and VAS are frequent in HoFH and that the phenotype has shifted towards calcific VAS as statins and lipoprotein apheresis improve survival in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehac339","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:27:09Z","timestamp":1656678429000},"page":"3227-3239","source":"Crossref","is-referenced-by-count":37,"title":["Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century"],"prefix":"10.1093","volume":"43","author":[{"given":"Alexandre M","family":"B\u00e9langer","sequence":"first","affiliation":[{"name":"Research Institute of the McGill University Health Centre , 1001, Boul. D\u00e9carie, Office EM1.2212, Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo E","family":"Akioyamen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-8028","authenticated-orcid":false,"given":"Isabelle","family":"Ruel","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre , 1001, Boul. D\u00e9carie, Office EM1.2212, Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Hales","sequence":"additional","affiliation":[{"name":"McGill University Health Centre Medical Libraries , Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre , 1001, Boul. D\u00e9carie, Office EM1.2212, Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2022090623584747600_ehac339-B1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9150(99)00109-4","article-title":"Familial hypercholesterolemia. Acceptor splice site (G\u2013&gt;C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G\u2013&gt;C]","volume":"146","author":"Yu","year":"1999","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosissup.2014.07.003","article-title":"What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?","volume":"15","author":"Santos","year":"2014","journal-title":"Atheroscler Suppl"},{"key":"2022090623584747600_ehac339-B3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European atherosclerosis society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"2022090623584747600_ehac339-B5","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"2022090623584747600_ehac339-B6","article-title":"Orphanet Report Series: Prevalence, incidence or reported number of published cases listed in alphabetical order of disease","year":"2021"},{"key":"2022090623584747600_ehac339-B7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.9.2.211","article-title":"Homozygous familial hypercholesterolemia among French Canadians in Quebec province","volume":"9","author":"Moorjani","year":"1989","journal-title":"Arteriosclerosis"},{"key":"2022090623584747600_ehac339-B8","first-page":"731","article-title":"Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia","volume":"76","author":"Haitas","year":"1990","journal-title":"Q J Med"},{"key":"2022090623584747600_ehac339-B9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur Heart J"},{"key":"2022090623584747600_ehac339-B11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0000000000000686","article-title":"Evidence for improved survival with treatment of homozygous familial hypercholesterolemia","volume":"31","author":"Belanger","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"2022090623584747600_ehac339-B12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022090623584747600_ehac339-B13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archpedi.1947.02020380071005","article-title":"Xanthoma tuberosum, aortic stenosis, coronary sclerosis and angina pectoris: report of a case in a boy thirteen years of age","volume":"73","author":"Cook","year":"1947","journal-title":"Am J Dis Child (1911)"},{"key":"2022090623584747600_ehac339-B14","first-page":"29","article-title":"Sudden death during childhood with xanthoma tuberosum: review of literature and report of a case","volume":"5","author":"Rigdon","year":"1950","journal-title":"J Insur Med (1946)"},{"key":"2022090623584747600_ehac339-B15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.1954.02950100019008","article-title":"Atherosclerosis and aortic stenosis in hypercholesteremic xanthomatosis","volume":"156","author":"Barr","year":"1954","journal-title":"J Am Med Assoc"},{"key":"2022090623584747600_ehac339-B16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-8703(54)90115-5","article-title":"Calcific aortic stenosis; study of serum cholesterol, with observations on calcific aortic stenosis in familial xanthomatosis and hypercholesteremia","volume":"48","author":"Boas","year":"1954","journal-title":"Am Heart J"},{"key":"2022090623584747600_ehac339-B17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2022090623584747600_ehac339-B18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2022090623584747600_ehac339-B19","doi-asserted-by":"crossref","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"2022090623584747600_ehac339-B20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2015.02.072","article-title":"High dose and long-term statin therapy accelerate coronary artery calcification","volume":"184","author":"Henein","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022090623584747600_ehac339-B21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.67.4.878","article-title":"Supravalvular aortic stenosis and coronary ostial stenosis in familial hypercholesterolemia: two-dimensional echocardiographic assessment","volume":"67","author":"Beppu","year":"1983","journal-title":"Circulation"},{"key":"2022090623584747600_ehac339-B22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/hrt.50.5.432","article-title":"Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia","volume":"50","author":"Ribeiro","year":"1983","journal-title":"Br Heart J"},{"key":"2022090623584747600_ehac339-B23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/clc.4960120608","article-title":"Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patients","volume":"12","author":"Brook","year":"1989","journal-title":"Clin Cardiol"},{"key":"2022090623584747600_ehac339-B24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.ATV.10.5.710","article-title":"Noninvasive ultrasound evaluation of pressure gradients in aortic root of homozygotes for familial hypercholesterolemia","volume":"10","author":"Faccenda","year":"1990","journal-title":"Arteriosclerosis"},{"key":"2022090623584747600_ehac339-B25","first-page":"22","article-title":"Echocardiographic changes in patients with heterozygous and homozygous familial hypercholesterolemia: correlation with clinical findings","volume":"58","author":"Tato","year":"1991","journal-title":"Bildgebung"},{"key":"2022090623584747600_ehac339-B26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/hrt.80.6.583","article-title":"Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia","volume":"80","author":"Rallidis","year":"1998","journal-title":"Heart"},{"key":"2022090623584747600_ehac339-B27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.98.6.509","article-title":"Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia","volume":"98","author":"Summers","year":"1998","journal-title":"Circulation"},{"key":"2022090623584747600_ehac339-B28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1744-9987.2008.00574.x","article-title":"Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years","volume":"12","author":"Palcoux","year":"2008","journal-title":"Ther Apher Dial"},{"key":"2022090623584747600_ehac339-B29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1567-5688(09)71805-7","article-title":"LDL-apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience","volume":"10","author":"Keller","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"2022090623584747600_ehac339-B30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1540-8175.2010.01169.x","article-title":"Noninvasive evaluation of coronary flow velocity reserve in homozygous familial hypercholesterolemia by transthoracic Doppler echocardiography","volume":"27","author":"Zhang","year":"2010","journal-title":"Echocardiography"},{"key":"2022090623584747600_ehac339-B31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jacl.2016.04.006","article-title":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: insights from SAFEHEART registry","volume":"10","author":"Alonso","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2022090623584747600_ehac339-B34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjcard.2016.05.042","article-title":"Effects of liver transplantation on lipids and cardiovascular disease in children with homozygous familial hypercholesterolemia","volume":"118","author":"Martinez","year":"2016","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B35","doi-asserted-by":"crossref","first-page":"3685265","DOI":"10.1155\/2017\/3685265","article-title":"Premature valvular heart disease in homozygous familial hypercholesterolemia","volume":"2017","author":"Fahed","year":"2017","journal-title":"Cholesterol"},{"key":"2022090623584747600_ehac339-B36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2018.01.034","article-title":"A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)","volume":"270","author":"Kayikcioglu","year":"2018","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjcard.2020.09.015","article-title":"Cardiovascular outcome of pediatric patients with bi-allelic (homozygous) familial hypercholesterolemia before and after initiation of multimodal lipid lowering therapy including lipoprotein apheresis","volume":"136","author":"Taylan","year":"2020","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF02349635","article-title":"Low density lipoprotein receptors and polyamine levels in human colorectal adenocarcinoma","volume":"30","author":"Notarnicola","year":"1995","journal-title":"J Gastroenterol"},{"key":"2022090623584747600_ehac339-B39","doi-asserted-by":"crossref","first-page":"C1033","DOI":"10.1152\/ajpcell.1995.268.4.C1033","article-title":"Isoform-specific induction of the low-density lipoprotein receptor gene by platelet-derived growth factor","volume":"268","author":"Rechtoris","year":"1995","journal-title":"Am J Physiol"},{"key":"2022090623584747600_ehac339-B40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-2275(20)42009-7","article-title":"Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor","volume":"37","author":"Pak","year":"1996","journal-title":"J Lipid Res"},{"key":"2022090623584747600_ehac339-B41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjcard.2020.09.015","article-title":"Cardiovascular outcome of pediatric patients with bi-allelic (homozygous) familial hypercholesterolemia before and after initiation of multimodal lipid lowering therapy including lipoprotein apheresis","volume":"136","author":"Taylan","year":"2020","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1536\/ihj.28.457","article-title":"Supravalvular and valvular aortic stenosis in homozygous familial hypercholesterolemia","volume":"28","author":"Aksut","year":"1987","journal-title":"Jpn Heart J"},{"key":"2022090623584747600_ehac339-B43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2020.12.080","article-title":"Supravalvular aortic stenosis and the risk of premature death among patients with homozygous familial hypercholesterolemia","volume":"145","author":"Zhang","year":"2021","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B44","first-page":"2508","article-title":"Phenotypical, clinical, and molecular aspects of adults and children with homozygous familial hypercholesterolemia in iberoamerica","volume":"40","author":"Alves","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022090623584747600_ehac339-B45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0828-282X(07)70889-9","article-title":"Surgical strategies for severe calcification of the aorta (porcelain aorta) in two patients with homozygous familial hypercholesterolemia","volume":"23","author":"Grenon","year":"2007","journal-title":"Can J Cardiol"},{"key":"2022090623584747600_ehac339-B46","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.athoracsur.2017.11.025","article-title":"Two cases of surgical management of supravalvular aortic stenosis in familial hypercholesterolemia","volume":"105","author":"Kakuta","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"2022090623584747600_ehac339-B47","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1097\/MJT.0b013e3181a2b1a6","article-title":"Statin therapy and aortic stenosis: a systematic review of the effects of statin therapy on aortic stenosis","volume":"17","author":"Loomba","year":"2010","journal-title":"Am J Ther"},{"key":"2022090623584747600_ehac339-B48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-007-9608-1","article-title":"Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination","volume":"308","author":"Trion","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"2022090623584747600_ehac339-B49","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022090623584747600_ehac339-B50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"2022090623584747600_ehac339-B51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2012.08.002","article-title":"Statins use and coronary artery plaque composition: results from the international multicenter CONFIRM registry","volume":"225","author":"Nakazato","year":"2012","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ehjci\/jet251","article-title":"Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN","volume":"15","author":"Puri","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022090623584747600_ehac339-B53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"Raber","year":"2015","journal-title":"Eur Heart J"},{"key":"2022090623584747600_ehac339-B54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"2022090623584747600_ehac339-B55","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"2022090623584747600_ehac339-B56","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"2022090623584747600_ehac339-B57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2459\/JCM.0b013e3283587267","article-title":"Statin use for nonrheumatic calcific aortic valve stenosis: a review with meta-analysis","volume":"14","author":"De Vecchis","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2022090623584747600_ehac339-B58","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.amjcard.2014.01.414","article-title":"Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)","volume":"113","author":"Arsenault","year":"2014","journal-title":"Am J Cardiol"},{"key":"2022090623584747600_ehac339-B59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022090623584747600_ehac339-B60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ahj.2011.03.016","article-title":"Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis","volume":"161","author":"Chan","year":"2011","journal-title":"Am Heart J"},{"key":"2022090623584747600_ehac339-B61","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022090623584747600_ehac339-B62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"2022090623584747600_ehac339-B63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022090623584747600_ehac339-B64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11883-019-0787-5","article-title":"Current role of lipoprotein apheresis","volume":"21","author":"Thompson","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"2022090623584747600_ehac339-B65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1744-9987.2009.00666.x","article-title":"Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia","volume":"13","author":"Coker","year":"2009","journal-title":"Ther Apher Dial"},{"key":"2022090623584747600_ehac339-B66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1526-0968.2003.00075.x","article-title":"Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis","volume":"7","author":"Kawaguchi","year":"2003","journal-title":"Therap Apher Dial"},{"key":"2022090623584747600_ehac339-B67","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s40520-020-01681-2","article-title":"The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis","volume":"33","author":"Conte","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"2022090623584747600_ehac339-B68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/ijms22020913","article-title":"Extracellular matrix in calcific aortic valve disease: architecture, dynamic and perspectives","volume":"22","author":"Di Vito","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022090623584747600_ehac339-B69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2012.08.026","article-title":"Aortic calcification: novel insights from familial hypercholesterolemia and potential role for the low-density lipoprotein receptor","volume":"226","author":"Fantus","year":"2013","journal-title":"Atherosclerosis"},{"key":"2022090623584747600_ehac339-B70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/34\/3227\/45669509\/ehac339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/34\/3227\/45669509\/ehac339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T19:59:56Z","timestamp":1662494396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/34\/3227\/6625868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":70,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2022,7,1]]},"published-print":{"date-parts":[[2022,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac339","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,7]]},"published":{"date-parts":[[2022,7,1]]}}}